Genetic contributions to SLE

Journal of Autoimmunity

Volumn 9, Issue 4, 1996, Pages 437-452

  Kono, Dwight H ^a   Theofilopoulos, Argyrios N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN TYROSINE PHOSPHATASE;

APOPTOSIS; AUTOIMMUNITY; DISEASE PREDISPOSITION; ETIOLOGY; GENE MAPPING; HUMAN; INHERITANCE; LUPUS VULGARIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030218083     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0061     Document Type: Review

References (182)

1. 1. Mills J.A. 1994. Systemic lupus erythematosus. N. Engl. J. Med. 330: 1871-1879
2. 2. Boumpas D.T., Austin H.A.I., Fessler B.J., Balow J.E., Klippel J.H., Lockshin M.D. 1995. Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122: 940-950
3. 3. Boumpas D.T., Fessler B.J., Austin H.A.I., Balow J.E., Klippel J.H., Lockshin M.D. 1995. Systemic lupus erythematosus: emerging concepts. Part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann. Intern. Med. 123: 42-53
4. 4. Siminovitch K.A., Chen P.J. 1993. B cells, immunoglobulin genes and variable gene utilization by autoantibodies. In The Molecular Pathology of Autoimmune Diseases. C.A. Bona, K.A. Siminovitch, M. Zanetti, and A.N. Theofilopoulos, eds. Harwood Academic Publ., New York, pp. 15-30
5. 5. Eilat D., Anderson W.F. 1994. Structure-function correlates of autoantibodies to nucleic acids. Lessons from immunochemical, genetic and structural studies. Mol. Immunol. 31: 1377-1390
6. 6. Shlomchik M.J., Mascelli M., Shan H., Radic M.Z., Pisetsky D., Marshak-Rothstein A., Weigert M. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171: 265-292
7. 7. Tillman D.M., Jou N.T., Hill R.J., Marion T.N. 1992. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation. J. Exp. Med. 176: 761-779
8. 8. Mohan C., Adams S., Stanik V., Datta S.K. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381
9. 9. Burlingame R.W., Rubin R.L., Balderas R.S., Theofilopoulos A.N. 1993. The genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91: 1687-1696
10. 10. Wofsy D. 1993. Treatment of murine lupus with anti-CD4 monoclonal antibodies. Immunol. Ser. 59: 221-236
11. 11. Finck B.K., Linsley P.S., Wofsy D. 1994. Treatment of murine lupus with CTLA4Ig. Science 265: 1225-1227
12. 12. Mohan C., Shi Y., Laman J.D., Datta S.K. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus. J. Immunol. 154: 1470-1480
13. 13. Lander E.S., Schork N.J. 1994. Genetic dissection of complex traits. Science 265: 2037-2048
14. 14. Collins F.S. 1995. Positional cloning moves from perditional to traditional. Nat. Genet. 9: 347-350
15. 15. Cooperative Human Linkage Center. 1994. A comprehensive human linkage map with centimorgan density. Science 265: 2049-2054
16. 16. Dietrich W., Copeland N.G., Gilbert D.J., Miller J.C., Jenkins N.A., Lander E.S. 1995. Mapping the mouse genome: current status and future prospects. Proc. Natl. Acad. Sci. USA 92: 10849-10853
17. 17. Love J.M., Knight A.M., McAleer M.A., Todd J.A. 1990. Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. Nucleic Acids Res. 18: 4123-4130
18. 18. Dietrich W., Katz H., Lincoln S.E., Shin H.-S., Friedman J., Dracopoli N.C., Lander E.S. 1992. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131: 423-447
19. 19. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C.L., Jenkins S.C., Palmer S.M., Balfour K.M., Rowe B., Farrall M., Barnett A.H., Bain S.C., Todd J.A. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature (London) 371: 130-136
20. 20. Hashimoto L., Habita C., Beressi J.P., Delepine M., Besse C., Cambon-Thomsen A., Deschamps I., Rotter J.I., Djoulah S., James M.R., Froguel P., Weissenbach J., Lathrop G.M., Julier C. 1994. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371: 161-164
21. 21. Todd J.A., Aitman T.J., Cornall R.J., Shosh S., Hall J.R.S., Hearne C.M., Knight A.M., Love J.M., McAleer M.A., Prins J.-B., Rodrigues N., Lathrop M., Pressey A., DeLarato N.H., Peterson L.B., Wicker L.S. 1991. Genetic analysis of autoimmune type 1 diabetes in mice. Nature 351: 542-547
22. 22. Risch N., Ghosh S., Todd J.A. 1993. Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 53: 702-714
23. 23. Lander E.S., Botstein D. 1989. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121: 185-199
24. 24. Paterson A.H., Lander E.S., Hewitt J.D., Peterson S., Lincoln S.E., Tanksley S.D. 1988. Resolution of quantitative traits into Mendelian factors by using a complete linkage map of restriction fragment length polymorphisms. Nature 335: 721-726
25. 25. Nelson S.F., McCusker J.H., Sander M.A., Kee Y., Modrich P., Brown P.O. 1993. Genome mismatch scanning: a new approach to genetic linkage mapping. Nat. Genet. 4: 946-951
26. 26. Lisitsyn N., Wigler M. 1993. Cloning the difference between two complex genomes. Science 259: 946-951
27. 27. Lisitsyn N.A., Segre J.A., Kusumi K., Lisitsyn N.M., Nadeau J.H., Frankel W.N., Wigler M.H., Lander E.S. 1994. Direct isolation of polymorphic markers linked to a trait by genetically directed representational difference analysis. Nat. Genet. 6: 57-63
28. 28. Rosenberg M., Przybylska M., Straus D. 1994. "RFLP substraction": a method for making libraries of polymorphic markers. Proc. Natl. Acad. Sci. USA 91: 6113-6117
29. 29. Jonsson J.J., Weissman S.M. 1995. From mutation mapping to phenotype cloning. Proc. Natl. Acad. Sci. USA 92: 83-85
30. 30. Todd J.A. 1995. Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl. Acad. Sci. USA 92: 8560-8565
31. 31. Kruglyak L., Lander E.S. 1995. High-resolution genetic mapping of complex traits. Am. J. Hum. Genet. 56: 1212-1223
32. 32. Hastbacka J., de la Chapelle A., Mahtani M.M., Clines G., Reeve-Daly M.P., Daly M., Hamilton B.A., Kusumi K., Trivedi B., Weaver A., Coloma A., Lovett M., Buckler A., Kaitila I., Lander E.S. 1994. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 78: 1073-1087
33. 33. Theofilopoulos, A.N. 1995. The basis of autoimmunity: Part II genetic predisposition. Immunol. Today 16: 150-158
34. 34. Theofilopoulos A.N., Dixon F.J. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269
35. 35. Merino R., Fossati L., Lacour M., Lemoine R., Higaki M., Izui S. 1992. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22: 295-299
36. 1 hybrid mice. Eur. J. Immunol. 16: 1631-1633
37. 1 mice. J. Exp. Med. 165: 1237-1251
38. 38. Ghatak S., Sainis K., Owen F.L., Datta S.K. 1987. T-cell-receptor β-and I-Aβ-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB×SWR crosses. Proc. Natl. Acad. Sci. USA 84: 6850-6853
39. 39. Nygard N.R., McCarthy D.M., Schiffenbauer J., Schwartz B.D. 1993. Mixed haplotypes and autoimmunity. Immunol. Today 14: 53-56
40. 1 mice detected by T cell clones. J. Immunol. 150: 4777-4787
41. 41. Drake C.G., Rozzo S.J., Hirschfeld H.F., Smarnworawong N.P., Palmer E., Kotzin B.L. 1995. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J. Immunol. 154: 2441-2447
42. 1 mice. Clin. Immunol. Immunopathol. 65: 308-314
43. 43. Morel L., Rudofsky U.H., Longmate J.A., Schiffenbauer J., Wakeland E.K. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229
44. 44. Chiang B.-L., Bearer E., Ansari A., Dorshkind K., Gershwin M.E. 1990. The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J. Immunol. 145: 94-101
45. 45. Merino R., Iwamoto M., Fossati L., Muniesa P., Araki K., Takahashi S., Huarte J., Yamamura K., Vassalli J.D., Izui S. 1993. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain. J. Exp. Med. 178: 1189-1197
46. 1 mice. Clin. Immunol. Immunopathol. 62: 227-234
47. 47. Cohen P.L., Creech E., Nakul-Aquaronne D., McDaniel R., Ackler S., Rapoport R.G., Sobel E.S., Eisenberg R.A. 1993. Antigen nonspecific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus-prone lpr mice. J. Clin. Invest. 91: 2761-2768
48. 1 mice. Immunogenetics 32: 295-299
49. 49. Theofilopoulos A.N. 1993. Immunologic genes in mouse lupus models. In The Molecular Pathology of Autoimmune Diseases. C.A. Bona, K.A. Siminovitch, M. Zanetti, and A.N. Theofilopoulos, eds. Harwood Academic Publ., New York, pp. 281-316
50. 50. Kofler R., McConahey P.J., Duchosal M.A., Balderas R.S., Theofilopoulos A.N., Dixon F.J. 1991. An autosomal recessive gene that delays expression of lupus in BXSB mice. J. Immunol. 146: 1375-1379
51. 1 hybrid mice. J. Clin. Invest. 94: 521-525
52. 52. Watanabe Y., Yoshida S.H., Ansari A.A., Gershwin M.E. 1994. The contribution of H-2bm12 and non H-2 background genes on murine lupus in NZB.H-2bm12/b mice. J. Autoimmunity 7: 153-164
53. 53. Murphy E.D., Roths J.B. 1976. A single gene for massive lymphoproliferation with immune complex disease in a new mouse strain MRL. In Proc. 16th Int. Congr. Hematology. Excerpta Medica, Amsterdam, p. 69
54. cg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 171: 519-531
55. cg: a novel mutant gene. Int. Rev. Immunol. 11: 193-210
56. 56. Roths J.B., Murphy E.D., Eicher E.M. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159: 1-20
57. cg in the heterozygous state on different genetic backgrounds. Cell. Immunol. 148: 91-102
58. 58. Watanabe T., Sakai Y., Miyawaki S., Shimizu A., Koiwai O., Ohno K. 1991. A molecular genetic linkage map of mouse chromosome 19, including the lpr, Ly-44, and Tdt genes. Biochem. Genet. 29: 325-335
59. 59. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. 1992. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
60. 60. Chu J.L., Drappa J., Parnassa A., Elkon K.B. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178: 723-730
61. 61. Wu J., Zhou T., He J., Mountz J.D. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178: 461-468
62. 62. Adachi M., Watanabe-Fukunaga R., Nagata S. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90: 1756-1760
63. 63. Mariani S.M., Matiba B., Armandola E.A., Krammer P.H. 1994. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24: 3119-3123
64. 64. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., Nagata S. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976
65. 65. Lynch D.H., Watson M.L., Alderson M.R., Baum P.R., Miller R.E., Tough T., Gibson M., Davis-Smith T., Smith C.A., Hunter K., Bhat D., Din W., Goodwin R.G., Seldin M.F. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136
66. 66. Hahne M., Peitsch M.C., Irmier M., Schroter M., Lowin B., Rousseau M., Bron C., Renno T., French L., Tschopp J. 1995. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7: 1381-1386
67. 67. Nagata S., Golstein P. 1995. The Fas death factor. Science 267: 1449-1456
68. 68. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., Nagata S. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148: 1274-1279
69. 69. Drappa J., Brot N., Elkon K.B. 1993. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90: 10340-10344
70. 70. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W, Roux E., Schooley K., Ramsdell F., Lynch D.H. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235
71. 71. Lynch D.H., Ramsdell F., Alderson M.R. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16: 569-574
72. 72. Clement M.V., Stamenkovic I. 1994. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J. Exp. Med. 180: 557-567
73. 73. Wong G.H., Goeddel D.V. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152: 1751-1755
74. 74. Eischen C.M., Dick C.J., Leibson P.J. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153: 1947-1954
75. 75. Tian Q., Taupin J., Elledge S., Robertson M., Anderson P. 1995. Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182: 865-874
76. 76. Cifone M.G., De Maria R., Roncaioli P., Rippo M.R., Azuma M., Lanier L.L., Santoni A., Testi R. 1994. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180: 1547-1552
77. 77. Gulbins E., Bissonnette R., Mahboubi A., Martin S., Nishioka W., Brunner T., Baier G., Baier-Bitterlich G., Byrd C., Lang F., Green D.R. 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2: 341-351
78. 78. Tepper C.G., Jayadev S., Liu B., Bielawska A., Wolff R., Yonehara S., Hannun Y.A., Seldin M.F. 1995. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92: 8443-8447
79. 79. Los M., Van de Craen M., Penning L.C., Schenk H., Westendorp M., Baeuerle P.A., Droge W., Krammer P.H., Fiers W., Schulze-Osthoff K. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83
80. 80. Enari M., Hug H., Nagata S. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81
81. 81. Tewari M., Dixit V.M. 1995. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270: 3255-3260
82. 82. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., Flavell R.A. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267: 2000-2003
83. 83. Su X., Zhou T., Wang Z., Yang P., Jope R.S., Mountz J.D. 1995. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2: 353-362
84. 84. McGahon A.J., Nishioka W.K., Martin S.J., Mahboubi A., Cotter T.G., Green D.R. 1995. Regulation of the Fas apoptotic cell death pathway by Abl. J. Biol. Chem. 270: 22625-22631
85. 85. Itoh N., Nagata S. 1993. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268: 10932-10937
86. 86. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512
87. 87. Stanger B.Z., Leder P., Lee T.H., Kim E., Seed B. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523
88. 88. Sato T., Irie S., Kitada S., Reed J.C. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411-415
89. 89. Suda T., Takahashi T., Golstein P., Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
90. 90. Suda T., Nagata S. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179: 873-879
91. 91. Gruss H.J., Dower S.K. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404
92. 92. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154: 3806-3813
93. 93. Ramsdell F., Seaman M.S., Miller R.E., Picha K.S., Kennedy M.K., Lynch D.H. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6: 1545-1553
94. 94. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
95. 95. Griffin T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192
96. 96. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., Krammer P.H., Runkel L. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182: 1223-1230
97. 97. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762
98. 98. Dhein J., Walczak H., Baumler C., Debatin K.M., Krammer P.H. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438-441
99. 99. Knipping E., Krammer P.H., Onel K.B., Lehman T.J.A., Mysler E., Elkon K.B. 1995. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum. 38: 1735-1737
100. 100. Goel N., Ulrich D.T., St Clair E.W., Fleming J.A., Lynch D.H., Seldin M.F. 1995. Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease. Arthritis Rheum. 38: 1738-1743
101. 101. Wu J., Zhou T., Zhang J., He J., Gause W.C., Mountz J.D. 1994. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA 91: 2344-2348
102. 102. Zhou T., Edwards C.K. 3d, Mountz J.D. 1995. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J. Exp. Med. 182: 129-137
103. 103. Singer P.A., Balderas R.S., McEvilly R.J., Bobardt M., Theofilopoulos A.N. 1989. Tolerance-related V beta clonal deletions in normal CD4-8-, TCR-alpha/beta+ and abnormal lpr and gld cell populations. J. Exp. Med. 170: 1869-1877
104. 104. Zhou T., Bleuthmann H., Zhang J., Edwards C.K. 3rd, Mountz J.D. 1992. Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice. J. Exp. Med. 176: 1063-1072
105. 105. Herron L.R., Eisenberg R.A., Roper E., Kakkanaiah V.N., Cohen P.L., Kotzin B.L. 1993. Selection of the T cell receptor repertoire in Lpr mice. J. Immunol. 151: 3450-3459
106. 106. Mogil R.J., Radvanyi L., Gonzalez-Quintial R., Miller R., Mills G., Theofilopoulos A.N., Green D.R. 1995. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7: 1451-1458
107. 107. Sidman C.L., Marshall J.D., von Boehmer H. 1995. Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur. J. Immunol. 22: 499-504
108. 108. Singer G.G., Abbas A.K. 1994. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365-371
109. 109. Russell J.H., Rush B., Weaver C., Wang R. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90: 4409-4413
110. 110. Bossu P., Singer G.G., Andres P., Ettinger R., Marshak-Rothstein A., Abbas A.K. 1993. Mature CD4+ lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J. Immunol. 151: 7233-7239
111. 111. Musette P., Pannetier C., Gachelin G., Kourilsky P. 1994. The expansion of a CD4+ T cell population bearing a distinctive beta chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection. Eur. J. Immunol. 24: 2761-2766
112. 112. Podack E.R. 1995. Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr. Opin. Immunol. 7: 11-16
113. 113. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
114. 114. Ju S.T., Panka D.J., Cui H., Ettinger R., el-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448
115. 115. Yang Y., Mercep M., Ware C.F., Ashwell J.D. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181: 1673-1682
116. 116. Hanabuchi S., Koyanagi M., Kawasaki A., Shinohara N., Matsuzawa A., Nishimura Y., Kobayashi Y., Yonehara S., Yagita H., Okumura K. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91: 4930-4934
117. 117. Ju S.T., Cui H., Panka D.J., Ettinger R., Marshak-Rothstein A. 1994. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CDS+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91: 4185-4189
118. 118. Lowin B., Hahne M., Mattmann C., Tschopp J. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370: 650-652
119. 119. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528-530
120. 120. Berke G. 1995. The CTL's kiss of death. Cell 81: 9-12
121. 121. Walsh C.M., Matloubian M., Liu C.C., Ueda R., Kurahara C.G., Christensen J.L., Huang M.T., Young J.D., Ahmed R., Clark W.R. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91: 10854-10858
122. 122. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., Lenardo M.J. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351
123. 123. Mixter P.F., Russell J.Q., Durie F.H., Budd R.C. 1995. Decreased CD4-CDS-TCR-alpha beta+ cells in lpr/lpr mice lacking beta 2-microglobulin. J. Immunol. 154: 2063-2074
124. 124. Ohteki T., Iwamoto M., Izui S., MacDonald H.R. 1995. Reduced development of CD4-8-B220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules. Eur. J. Immunol. 25: 37-41
125. 125. Maldonado M.A., Eisenberg R.A., Roper E., Cohen P.L., Kotzin B.L. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181: 641-648
126. + double-negative T cells as the predominant populations in enlarged lymph nodes. J. Immunol. 154: 4986-4995
127. 127. Merino R., Fossati L., Iwamoto M., Takahashi S., Lemoine R., Ibnou-Zekri N., Pugliatti L., Merino J., Izui S. 1995. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4-CD8-double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J. Autoimmun. 8: 33-45
128. 128. Altman A. 1994. Abnormal antigen receptor-initiated signal transduction in lpr T lymphocytes. Semin. Immunol. 6: 9-17
129. 129. Watanabe D., Suda T., Hashimoto H., Nagata S. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14: 12-18
130. 130. Theofilopoulos A.N., Balderas R.S., Gozes Y., Aguado M.T., Hang L.M., Morrow P.R., Dixon F.J. 1985. Association of the lpr gene with a graft-versus-host-like disease. J. Exp. Med. 162: 1-18
131. 131. Chu J.L., Ramos P., Rosendorff A., Nikolic-Zugic J., Lacy E., Matsuzawa A., Elkon K.B. 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181: 393-398
132. 132. Jevnikar A.M., Grusby M.J., Glimcher L.H. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179: 1137-1143
133. 133. Sobel E.S., Katagiri T., Katagiri K., Morris S.C., Cohen P.L., Eisenberg R.A. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173: 1441-1449
134. 134. Reap E.A., Leslie D., Abrahams M., Eisenberg R.A., Cohen P.L. 1995. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154: 936-943
135. 135. Roark J.H., Kuntz C.L., Nguyen K.A., Caton A.J., Erikson J. 1995. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181: 1157-1167
136. 136. Carsetti R., Kohler G., Lamers M.C. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181: 2129-2140
137. 137. Rathmell J.C., Goodnow C.C. 1994. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153: 2831-2842
138. + T cells. Nature 376: 181-183
139. 139. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., Cui H., Ju S.T., Marshak-Rothstein A. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163-165
140. 140. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I.A., Debatin K.M., Fischer A., de Villartay J.P. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349
141. 141. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., Puck J.M. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946
142. 142. Mysler E., Bini P., Drappa J., Ramos P., Friedman S.M., Krammer P.H., Elkon K.B. 1994. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93: 1029-1034
143. 143. Ohsako S., Hara M., Harigai M., Fukasawa C., Kashiwazaki S. 1994. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunopathol. 73: 109-114
144. 144. Strasser A., Whittingham S., Vaux D.L., Bath M.L., Adams J.M., Cory S., Harris A.W. 1991. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88: 861-8665
145. 145. Reap E.A., Felix N.J., Wolthusen P.A., Kotzin B.L., Cohen P.L., Eisenberg R.A. 1995. bcl-2 transgenic lpr mice show profound enhancement of lymphadenopathy. J. Immunol. 155: 5455-5462
146. 146. Moroy T., Grzeschiczek A., Petzold S., Hartmann K.U. 1993. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl. Acad. Sci. USA 90: 10734-10738
147. 147. Hibbs M.L., Tarlinton D.M., Armes J., Grail D., Hodgson G., Maglitto R., Stacker S.A., Dunn A.R. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311
148. 148. Nishizumi H., Taniuchi I., Yamanashi Y., Kitamura D., Ilic D., Mori S., Watanabe T., Yamamoto T. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560
149. 149. Merino R., Fossati L., Izui S. 1992. The lupus-prone BXSB strain: the Yaa gene model of systemic lupus erythematosus. Semin. Immunopathol. 14: 141-157
150. 150. Murphy E.D., Roths J.B. 1979. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22: 1188-1194
151. 151. Eisenberg R.A., Izui S., McConahey P.J., Hang L.M., Peters C.J., Theofilopoulos A.N., Dixon F.J. 1980. Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J. Immunol. 125: 1032-1036
152. 152. Lahita R.G., Chiorazzi N., Gibofsky A., Winchester R.J., Kunkel H.G. 1983. Familiar systemic erythematosus in males. Arthritis Rheum. 26: 39-44
153. 153. Hudgins C.C., Steinberg R.T., Klinman D.M., Reeves M.J.P, Steinberg A.D. 1985. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 134: 3849-3854
154. 1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18: 911-915
155. 155. Merino R., Shibata T., de Kossodo S., Izui S. 1989. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur. J. Immunol. 19: 2131-2137
156. 156. Suzuka H., Yoshifusa H., Nakamura Y., Miyawaki S., Shibata Y. 1993. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus. Autoimmunity 14: 275-282
157. 157. Jansson L., Holmdahl R. 1994. The Y chromosome-linked "autoimmune accelerating" yaa gene suppresses collagen-induced arthritis. Eur. J. Immunol. 24: 1213-1217
158. 158. Merino R., Fossati L., Lacour M., Izui S. 1991. Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)-Yaa-bone marrow chimeric mice. J. Exp. Med. 174: 1023-1029
159. 159. Fossati L., Iwamoto M., Merino R., Izui S. 1995. Selective enhancing effect of the Yaa gene on immune responses against self and foreign antigens. Eur. J. Immunol. 25: 166-173
160. 160. Izui S., Merino R., Fossati L., Iwamoto M. 1994. The role of the Yaa gene in lupus syndrome. Int. Rev. Immunol. 11: 211-230
161. 161. Green M.C., Shultz L.D. 1975. Motheaten, an immunodeficient mutant of the mouse. J. Hered. 66: 250-258
162. 162. Bignon J.S., Siminovitch K.A. 1994. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. Immunopathol. 73: 168-179
163. 163. Shultz L.D., Schweitzer P.A. Rajan T.V., Yi T., Ihle J.N., Matthews R.J., Thomas M.L., Beier D.R. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445-1454
164. 164. Tsui H.W., Siminovitch K.A., deSouza L., Tsui F.W.L. 1995. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet. 4: 124-129
165. 165. Kozlowski M., Mlinaric I.-R., Feng G.H., Shen R., Pawson T., Siminovitch K.A. 1993. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178: 2157-2163
166. 166. Thomas M.L. 1995. Of ITAMs and ITIMs: turning on and off the B cell antigen receptor. J. Exp. Med. 181: 1953-1956
167. 167. D'Ambrosio D., Hippen K.L., Minskoff S.A., Mellman I., Pani G., Siminovitch K.A., Cambier J.C. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcgRIIB1. Science 268: 293-297
168. 168. Karlund J.K. 1985. Transformation of cells by an inhibitor of phosphatase acting on phosphotyrosine in proteins. Cell 41: 707-717
169. 169. Ramponi G., Ruggiero M., Raugei G., Berti A., Modesti A., Degl'Innocenti D., Magnelli L., Pazzagli C., Chiarugi V.P., Camici G. 1992. Overexpression of a synthetic phosphotyrosine protein phosphatase gene inhibits normal and transformed cell growth. Int. J. Cancer 41: 652-656
170. 170. Brown-Shimer S., Johnson K.A,. Hill D.E., Bruskin A.M. 1992. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res. 52: 478-482
171. 171. Pani G., Kozlowski M., Cambier J.C., Mills G.B., Siminovitch K.A. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181: 2077-2084
172. 172. Doody G.M., Justement L.B., Delibrias C.C., Matthews R.J., Lin J., Thomas M.L., Fearon D.T. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269: 242-244
173. 173. Morris D.L., Rothstein T.L. 1994. Decreased surface IgM receptor-mediated activation of phospholipase Cgamma2 in B-1 lymphocytes. Int. Immunol. 6: 1011-1016
174. 174. Knight J.G., Adams D.D. 1981. Genes determining autoimmune disease in New Zealand mice. J. Clin. Lab. Immunol. 5: 165-170
175. 175. Shirai T. 1982. The genetic basis of autoimmunity in murine lupus. Immunol. Today 3: 187-191
176. 176. Watson M.L., Rao J.K., Gilkeson G.S., Ruiz P., Eicher E.M., Pisetsky D.S., Matsuzawa A., Rochelle J.M., Seldin M.F. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176: 1645-1656
177. 1 mice. Proc. Natl. Acad. Sci. USA 91: 4062-4066.
178. 1 mice. Int. Immunol. 6: 1857-1864
179. 179. Kono D.H., Burlingame R.W., Owens D.G., Kuramochi A., Balderas R.S., Balomenos D., Theofilopoulos A.N. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172
180. 180. Rudofsky U.H., Evans B.D., Balaban S.L., Mottironi V.D., Gabrielsen A.E. 1993. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab. Invest. 68: 419-426
181. 181. Theofilopoulos, A.N. 1992. Murine models of SLE. In Systemic Lupus Erythematosus, (second edition) R.G. Lahita, ed. Churchill Livingstone Inc, New York, pp. 121-194
182. 182. Ghosh S., Palmer S.M., Rodrigues N.R., Cordell H.J., Hearne C.M., Cornall R.J., Prins J.-B., McShane P., Lathrop G.M., Peterson L.B., Wicker L.S., Todd J.A. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genet. 4: 404-409